Irene G. C.
- Country
- Spain
- Department
- Hematología
Research Overview
- Phase III Trial Comparing Extended Lenalidomide-Bortezomib-Dexamethasone with Early Rescue vs. Isatuximab-Lenalidomide-Bortezomib-Dexamethasone vs. Isatuximab-Lenalidomide-Iberdomide-Dexamethasone in Newly Diagnosed Multiple Myeloma Candidates for Autologous Stem Cell Transplantation
- Evaluation of Alternative Dosing Regimens of Belantamab Mafodotin in Relapsed or Refractory Multiple Myeloma Patients
Data & Insights
Has run more than one trial at 3 of 64 partner sites.
Specializations
Multiple Myeloma Research
This investigator specializes in treating multiple myeloma, with particular emphasis on both newly diagnosed and relapsed/refractory cases. Their research encompasses innovative therapeutic approaches for hematologic malignancies.
- Newly Diagnosed Multiple Myeloma (NDMM)
- Relapsed/Refractory Multiple Myeloma (RRMM)
- Autologous Stem Cell Transplantation (ASCT)
The investigator's work focuses on evaluating novel treatment combinations and alternative dosing strategies for optimal patient outcomes.
Novel Therapeutic Approaches
The investigator explores innovative treatment combinations including immunotherapy agents and targeted therapies. Their research involves investigating various drug combinations and treatment regimens.
- Immunotherapy Development
- Combination Therapy Strategies
- Alternative Dosing Regimens
Their work includes evaluation of novel agents such as isatuximab and belantamab mafodotin in various therapeutic contexts.
Treatment Response Assessment
The investigator specializes in evaluating treatment effectiveness through advanced diagnostic methods, including minimal residual disease (MRD) assessment techniques.
- Next-Generation Flow Cytometry
- Response Monitoring
- Treatment Optimization
Their research incorporates sophisticated monitoring approaches to assess therapeutic efficacy and guide treatment decisions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.